By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • Health Topics
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal โ†’
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • Health Topics
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal โ†’
  • About GMJ News
Follow US
GMJ News > GMJ Briefs > ๐Ÿšจ Class 3 Medicines Recall: Orbit Pharma Limited, Cyclizine Lactate 50 mg/ml Solution for injection, EL(26)A/29

๐Ÿšจ Class 3 Medicines Recall: Orbit Pharma Limited, Cyclizine Lactate 50 mg/ml Solution for injection, EL(26)A/29

GMJ
Last updated: 17/06/2026 13:07
By
Prof. Giorgi Pkhakadze
Share
0 Min Read
SHARE
1 min read|50 words
๐Ÿšจ Breaking Newsvia MHRA Alerts

Orbit Pharma Limited is recalling a specific batch of Cyclizine Lactate 50 mg/ml Solution for injection as a precautionary measure due to Good Manufacturing Practice (GMP) deficiencies identified at the manufacturing site.

This is a developing story.

Source: Class 3 Medicines Recall: Orbit Pharma Limited, Cyclizine Lactate 50โ€ฆ

Was this article helpful?

Share This Article
Facebook LinkedIn Bluesky Copy Link Print
GMJ
ByProf. Giorgi Pkhakadze
Follow:
Prof. Giorgi Pkhakadze, MD, MPH, PhD, is Editor-in-Chief of the Georgian Medical Journal and Chair of the Public Health Institute of Georgia (PHIG). He is Professor and Head of the Department of Social and Behavioural Sciences at David Tvildiani Medical University, and Secretary/Treasurer of the UEMS Section of Public Health. ORCID: 0000-0001-7609-4515.

Submit Your Paper โ†’

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript โ†’
FDA-Approved Drug Restores Immunotherapy Efficacy in Rare Liver Cancer by Releasing Trapped T Cells

Researchers have identified that rare liver cancers evade immunotherapy by trapping immune…

Timing of Second Stent Placement After Heart Attack: New Trial Challenges Immediate Intervention Strategy

A randomized controlled trial published in the New England Journal of Medicine…

Africa’s Regional Research Hubs: Building Local Capacity for Drug Manufacturing and Health Innovation

Africa needs strategically distributed regional research and development hubs to accelerate local…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript โ†’

You Might Also Like

Illustration of engineered heart muscle tissue derived from induced pluripotent stem cells showing cardiac myocytes in three-dimensional tissue construct

From Laboratory to Patient Care: Engineered Cardiac Tissue Enters Clinical Phase

By
Prof. Giorgi Pkhakadze
23/07/2026
Jakarta hospital survey showing antibiotic resistance patterns in bacterial infections

Jakarta’s Hospital Network Maps Antibiotic Resistance Crisis Across Multiple Facilities

By
Prof. Giorgi Pkhakadze
07/06/2026
Illustration of migraine pathways and CGRP receptor antagonism mechanism in vestibular migraine treatment

Gepants Emerge as New Therapeutic Avenue for Vestibular Migraine Management

By
Prof. Giorgi Pkhakadze
06/08/2026

๐Ÿšจ M 7.3 – 58 km WSW of Puerto Madero, Mexico

By
Prof. Giorgi Pkhakadze
17/07/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News โ€” Click here

Join Community
ยฉ 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up